ID
12738
Beschrijving
Phase I Study of Adoptive Immunotherapy With Enriched and Expanded Autologous Natural Killer (NK) Cells for Patients With Ph+ Acute Lymphoblastic Leukemia (ALL); ODM derived from: https://clinicaltrials.gov/show/NCT02185781
Link
https://clinicaltrials.gov/show/NCT02185781
Trefwoorden
Versies (1)
- 17-12-15 17-12-15 -
Geüploaded op
17 december 2015
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Acute Lymphoblastic Leukemia NCT02185781
Eligibility Acute Lymphoblastic Leukemia NCT02185781
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beschrijving
concomitant therapy
Datatype
boolean
Alias
- UMLS CUI [1]
- C1707479
Beschrijving
contraindication
Datatype
boolean
Alias
- UMLS CUI [1]
- C1301624
Beschrijving
infection
Datatype
boolean
Alias
- UMLS CUI [1]
- C0009450
Beschrijving
autoimmune symptoms
Datatype
boolean
Alias
- UMLS CUI [1]
- C0004364
Beschrijving
pregnant or breastfeeding
Datatype
boolean
Alias
- UMLS CUI [1]
- C0549206
- UMLS CUI [2]
- C0006147
Beschrijving
Study subject participation status
Datatype
boolean
Alias
- UMLS CUI [1]
- C2348568
Beschrijving
any physical or psychological impediment in a patient that could lead the investigator to suspect his/her poor compliance to the protocol.
Datatype
boolean
Alias
- UMLS CUI [1]
- C1321605
- UMLS CUI [2]
- C0439801
- UMLS CUI [3]
- C0009488
Similar models
Eligibility Acute Lymphoblastic Leukemia NCT02185781
- StudyEvent: Eligibility
C0232741 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
C0018724 (UMLS CUI [1,2])
C0006147 (UMLS CUI [2])
C0439801 (UMLS CUI [2])
C0009488 (UMLS CUI [3])